Skip to content

Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery

Randomized Controlled Trial Prospective Single-center Open Evaluating the Efficacy of Supplementation (Adapted to the Post-operative Period) Current Protein After Bariatric Surgery Like Sleeve Gastrectomy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02712086
Acronym
PROTISLEEVE
Enrollment
90
Registered
2016-03-17
Start date
2016-10-19
Completion date
2023-10-30
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy. Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.

Detailed description

The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy. Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain. There is still no study evaluating the protein supplementation adapted patients after sleeve gastrectomy on maintaining lean body mass.

Interventions

OTHERprotein supplementation

Protein supplementation : Protein intake of 30 grams of protein in addition to the usual inputs (to the recommended amounts of 60 to 120 g per day), upon the resumption of oral intake until the fifth week after sleeve gastrectomy.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* surgical management of sleeve gastrectomy kind

Exclusion criteria

* food allergies * Weight\> 135 kg (maximum weight supported by the DXA) * orthopedic prosthesis (hip, knee ...) that would make it impossible to interpret the measurement of DXA * History of bariatric surgery: adjustable gastric banding, vertical banded gastrectomy ...

Design outcomes

Primary

MeasureTime frame
Changes in lean mass (kg) will be assessed at the level of whole-body dual-energy X-ray absorptiometry (DXA)up to 1 month

Secondary

MeasureTime frameDescription
food diary5 weeks after the hospital dischargeThe actual protein intake will be assessed using a food diary over 5 weeks completed by the patient
change rate IGF1, IGFBP3up to 1 monthchange rate IGF1, IGFBP3 between hospitalization and 1 month of hospital discharge
the quality of lifeup to 1 monthThe evolution of the quality of life will be assessed through a specific scale, Baros score.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORDavid NOCCA

University Hospital, Montpellier

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026